Medicare Price Talks Are Moving Toward More Arthritis Drugs: What Patients Taking Xeljanz, Orencia, Cosentyx, or Cimzia Should Know
As of April 2, 2026, nothing changes at the pharmacy yet for Medicare patients taking Xeljanz, Orencia, Cosentyx, or Cimzia. What changed is that Medicare has selected these drugs for its third negotiation cycle, manufacturers are participating, and any negotiated prices would not begin until January 1, 2028.
